Group President, Global Businesses and the Americas · ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Kevin Thornal

FY2025 is the first fiscal year CompBrief holds for Kevin Thornal as a named executive officer of ZIMMER BIOMET; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$6,210,746

Compensation figures as of the proxy filed April 1, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-09-24.

Kevin Thornal compensation by year

ZIMMER BIOMET Summary Compensation Table · the one fiscal year held
In US dollars, as ZIMMER BIOMET reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$405,385
Bonus$0
Stock awards$5,300,085
Option awards$0
Non-equity incentive$505,275
Pension and deferred compensation$0
All other$0
Total$6,210,746

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ZIMMER BIOMET HOLDINGS, INC. DEF 14A filed April 1, 2026, accession 0001193125-26-135661, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
PSU30,474$2,740,222—
RSU29,870$2,685,910—

Per the Outstanding Equity Awards at Fiscal Year-End table in ZIMMER BIOMET HOLDINGS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

4 Form 4 lines since the FY2025 proxy (filed April 1, 2026)
current to 2026-09-24 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-11Sale—5,691$92.950
2026-08-01Exercise or conversion—9,957$0.009,957
2026-08-01Exercise or conversion derivative—9,957$0.0019,913
2026-08-01Tax withholding—4,266$92.685,691

The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments ZIMMER BIOMET discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Voluntary resignation$0$0$0$0
Change in control and involuntary termination$1,700,000$4,142,603$66,142—
Death$0$0$0$0
Disability$0$0$0$0
Change in control and resignation for good reason$1,700,000$4,142,603$66,142—
Retirement$0$0$0$0
Involuntary for cause$0$0$0$0
Involuntary termination without cause$850,000$0$32,627—

Per the Potential Payments Upon Termination or Change in Control table in ZIMMER BIOMET HOLDINGS, INC.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

ZIMMER BIOMET’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ivan TornosChairman, President and Chief Executive Officer$16,106,550
Jehanzeb NoorSenior Vice President, Chief Strategy, Business Development, Innovation and Transformation Officer$7,874,209
Suketu UpadhyayChief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain$6,211,805
Kevin Thornal · this pageGroup President, Global Businesses and the Americas$6,210,746
Wilfred van ZuilenGroup President, Europe, Middle East and Africa (EMEA)$4,139,409

The full ZIMMER BIOMET compensation record

free company brief

This page is one person within ZIMMER BIOMET's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ZIMMER BIOMET's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ZIMMER BIOMET's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy